Report #2860306

Overview

Sex

Female

Age

Age unknown

State

—

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

A female patient received an IM dose of Priorix instead of SC.; received at 28 years of age; This non-serious case was reported by a other health professional via call center representative and described the occurrence of subcutaneous injection formulation administered by other route in a 28-year-old female patient who received MMR (Priorix) (batch number GE974, expiry date 01-DEC-2026) for prophylaxis. On an unknown date, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced subcutaneous injection formulation administered by other route (Verbatim: A female patient received an IM dose of Priorix instead of SC.) and inappropriate age at vaccine administration (Verbatim: received at 28 years of age). The outcome of the subcutaneous injection formulation administered by other route and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 25-AUG-2025 The health care professional reported that a 28 years old female patient received Priorix vaccine intramuscular instead of subcutaneous, which led to subcutaneous injection formulation administered by other route and inappropriate age at vaccine administration . The reporter was ask did it need a revaccination and what did have to do next.